BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15598775)

  • 1. Testicular cancer incidence in eight northern European countries: secular and recent trends.
    Richiardi L; Bellocco R; Adami HO; Torrång A; Barlow L; Hakulinen T; Rahu M; Stengrevics A; Storm H; Tretli S; Kurtinaitis J; Tyczynski JE; Akre O
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2157-66. PubMed ID: 15598775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
    Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in testicular germ cell cancer incidence in Australia.
    Baade P; Carrière P; Fritschi L
    Cancer Causes Control; 2008 Dec; 19(10):1043-9. PubMed ID: 18478339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark.
    Jacobsen R; Møller H; Thoresen SØ; Pukkala E; Kjaer SK; Johansen C
    Int J Androl; 2006 Feb; 29(1):199-204. PubMed ID: 16371112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
    Hakulinen T; Andersen A; Malker B; Pukkala E; Schou G; Tulinius H
    Acta Pathol Microbiol Immunol Scand Suppl; 1986; 288():1-151. PubMed ID: 3465196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.
    Weir HK; Marrett LD; Moravan V
    CMAJ; 1999 Jan; 160(2):201-5. PubMed ID: 9951441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic clustering of testicular cancer incidence in the northern part of The Netherlands.
    Sonneveld DJ; Schaapveld M; Sleijfer DT; Meerman GJ; van der Graaf WT; Sijmons RH; Koops HS; Hoekstra HJ
    Br J Cancer; 1999 Dec; 81(7):1262-7. PubMed ID: 10584892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtype-specific incidence of testicular cancer in Germany: a pooled analysis of nine population-based cancer registries.
    Stang A; Rusner C; Eisinger B; Stegmaier C; Kaatsch P
    Int J Androl; 2009 Aug; 32(4):306-16. PubMed ID: 18179558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doubling of testicular cancer incidence rate over the last 20 years in southern France.
    Walschaerts M; Huyghe E; Muller A; Bachaud JM; Bujan L; Thonneau P
    Cancer Causes Control; 2008 Mar; 19(2):155-61. PubMed ID: 18236173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
    Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence of testicular cancer worldwide: a review.
    Huyghe E; Matsuda T; Thonneau P
    J Urol; 2003 Jul; 170(1):5-11. PubMed ID: 12796635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular cancer.
    Forman D; Møller H
    Cancer Surv; 1994; 19-20():323-41. PubMed ID: 7534631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frailty modelling of testicular cancer incidence using Scandinavian data.
    Moger TA; Aalen OO; Halvorsen TO; Storm HH; Tretli S
    Biostatistics; 2004 Jan; 5(1):1-14. PubMed ID: 14744824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
    Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
    Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting the international trends in testicular seminoma and nonseminoma incidence.
    Bray F; Ferlay J; Devesa SS; McGlynn KA; Møller H
    Nat Clin Pract Urol; 2006 Oct; 3(10):532-43. PubMed ID: 17031378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing incidence of testicular cancer--birth cohort effects.
    Ekbom A; Akre O
    APMIS; 1998 Jan; 106(1):225-9; discussion 229-31. PubMed ID: 9524583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)].
    Post PN; Casparie MK; ten Kate FJ; Oosterhuis JW
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1150-4. PubMed ID: 15211966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular cancer in Luxembourg: incidence and outcome in relation to the different histo-pathological types (1980-2004).
    Scheiden R; Hein T; Wagener C; Kieffer N; Lamy S; Capesius C
    Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):521-39. PubMed ID: 19024372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population based incidence and age distribution of spermatocytic seminoma.
    Carrière P; Baade P; Fritschi L
    J Urol; 2007 Jul; 178(1):125-8. PubMed ID: 17499277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.